Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, FDA, 10903 New Hampshire Ave, Bldg 22, Rm 4176, Silver Spring, MD 20993, United States.
Pharmacol Res. 2017 Sep;123:1-9. doi: 10.1016/j.phrs.2017.06.003. Epub 2017 Jun 15.
Platelets undergo a process of developmental maturation, and hence its regulation of vascular integrity and control of hemostasis at various stages of neonatal ages deserves better characterization. Functional assays for platelets require a larger volume of blood than what is feasible to collect in neonates, creating a technical hurdle that has been a challenge to investigate neonatal platelets. For this reason, the current knowledge of neonatal platelet function has been based on studies from cord blood-derived platelets as a surrogate for neonatal peripheral blood. Studies indicate that neonatal platelets are hypofunctional to various agonists, although neonates tend to maintain normal hemostasis. This apparently paradoxical finding may be due to several factors, such as elevated functionally potent von Willebrand factor multimers or hematocrit levels, in the neonatal blood that enhance the platelet and vessel wall interaction, and counteract platelet hyporeactivity. This review describes the functional characteristics of neonatal platelets, differences in platelet reactivity between neonates and adults, and potential biomarkers of platelet activation.
血小板经历发育成熟的过程,因此在新生儿不同阶段其对血管完整性的调节和止血的控制值得更好地描述。血小板的功能检测需要比新生儿实际可行的采血量大得多的血量,这就造成了一个技术障碍,使得研究新生儿血小板成为一项挑战。由于这个原因,目前对新生儿血小板功能的认识是基于来自脐血衍生血小板的研究,作为新生儿外周血的替代物。研究表明,新生儿血小板对各种激动剂的反应性降低,尽管新生儿往往能维持正常的止血功能。这种明显的矛盾发现可能归因于新生儿血液中存在几种因素,如功能强大的 von Willebrand 因子多聚体或血细胞比容水平升高,这些因素增强了血小板与血管壁的相互作用,并抵消了血小板反应性降低。这篇综述描述了新生儿血小板的功能特征、新生儿和成人血小板反应性的差异,以及血小板激活的潜在生物标志物。